EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 36C24026K1010
- Contractor
- MCKESSON CORPORATION
- Awarding agency
- Department of Veterans Affairs
- Sub-agency / office
- Department of Veterans Affairs
- Award amount
- $1,194,619,137
- Period of performance
- Jul 1, 2026 – Jul 31, 2026
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- PSC 6505
- Place of performance
- IRVING, TX, 750392402, USA
- Competition
- FULL AND OPEN COMPETITION
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,194,619,137 · Obligated $1,194,619,137 · Potential value $1,194,619,137 · Latest action obligation $1,194,619,137
- Parent award
- 36W79720D0001
Public award description
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY
Related intelligence
Related Federal Awards
- · 36C25926F0310 — EMERGENCY PHARMACY CARVYKTI FOR RMR · JANSSEN BIOTECH INC · Department of Veterans Affairs · $384,719
- · 36C26226N0738 — Federal award — Department of Veterans Affairs · BRISTOL-MYERS SQUIBB COMPANY · Department of Veterans Affairs · $364,139
- · 36C24626P0824 — OMINCELL IVX WORKFLOW MANAGEMENT (4 DEVICES), IVX LABEL SFW, IVX COLOR PRINTER, IVX ZEBRA BARCODE SCANNER, · TRILLAMED LLC · Department of Veterans Affairs · $268,200
- · 36C77026N0048 — Federal award — Department of Veterans Affairs · MERZ PHARMACEUTICALS, LLC · Department of Veterans Affairs · $236,612
- · 36C24626N1034 — Federal award — Department of Veterans Affairs · PARTNER THERAPEUTICS, INC. · Department of Veterans Affairs · $72,362
- · 36C26126P1178 — SEPHIENCE (SEPIAPTERIN) ORAL POWDER · OPTUM FRONTIER THERAPIES II, LLC · Department of Veterans Affairs · $58,374